Postprandial lipid metabolism: The missing link between life-style habits and the increasing incidence of metabolic diseases in western countries?

Open Translational Medicine Journal

Volumn 2, Issue , 2010, Pages 1-13

  Bravo, Elena ^a   Napolitano, Mariarosaria ^a   Botham, Kathleen M ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Lifestyle; Obesity; Postprandial lipemia; Triglyceride rich lipoproteins; Type 2 diabetes

Indexed keywords

BIOLOGICAL MARKER; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; SATURATED FATTY ACID;

ADIPOSE TISSUE; ALCOHOL CONSUMPTION; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIET; EXERCISE; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; LIFESTYLE; LIPID ANALYSIS; LIPID METABOLISM; METABOLIC DISORDER; METABOLIC SYNDROME X; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; RENOVASCULAR DISEASE; SMOKING; TEST MEAL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; WESTERN HEMISPHERE;

EID: 77955165542     PISSN: None     EISSN: 18763995     Source Type: Journal    
DOI: 10.2174/1876399501002010001     Document Type: Article

References (145)

1. Allender S, Scarborough P, Peto V, et al. European Cardiovascular Disease Statistics 2008 ed. European Heart Network. Available from http://www.ehnheart.org/
2. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart Disease and Stroke Statistics-2009 Update. A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119: e21-e181.
3. Wing J, Winlansky ME. Lifestyle choices and endothelial function: risk and relevance. Curr Vasc Pharmacol 2009; 7: 209-24.
4. Lopez-Miranda J, Williams C, Lairon D. Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism. Br J Nutr 2007; 98: 458-73
5. Perez-Martinez P, Lopez-Miranda JL, Perez-Jiminez F, Ordovas JM. Influence of genetic factors in the modulation of postprandial lipemia. Atheroscler Suppl 2008; 9: 49-55.
6. Sharrett AR, Heiss G, Chambless LE, et al. Metabolic and lifestyle determinants of postprandial lipemia differ from those of fasting triglycerides. Arterioscler Thromb Vasc Biol 2001; 21: 275-81.
7. Redgrave TG. Formation and metabolism of chylomicrons. Int Rev Physiol 1983; 28:103-30.
8. Yu KC, Cooper AD. Postprandial lipoproteins and atherosclerosis. Front Biosci 2001; 6: D332-54.
9. Nguyen P, Leray V, Diez M, et al. Liver Lipid Metabolism. J Anim Physiol Anim Nutr (Berl) 2008; 92: 272-83.
10. Gibbons GF. Assembly and secretion of hepatic very-low-density lipoprotein. Biochem J 1990; 268: 1-13.
11. Zilversmit DB. Atherogenesis: A postprandial phenomenon. Circulation 1979; 60: 473-85.
12. Alipour A, Elte JWF, van Zaanen HCT, Rietveld AP, Castro Cabezas M. Novel aspects of postprandial lipemia in relation to atherosclerosis. Atheroscler Suppl 2008; 9: 39-44.
13. O'Keefe JH, Bell DSH. Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am J cardiol 2007; 100: 899-904.
14. Hyson D, Rutledge JC, Berglund L. Postprandial lipemia and cardiovascular disease. Curr Atheroscler Rep 2003; 5: 437-44.
15. Goldberg IR, Kako Y, Lutz EP. Responses to eating: lipoproteins, lipolytic products and atherosclerosis. Curr Opin Lipidol 2000; 11: 235-41.
16. Takeichi S, Nakajima Y, Yukawa N et al. Association of plasma triglyceride-rich lipoprotein remnants with "Pokkuri disease". Legal Med 2001; 3: 84-94.
17. Nakajima K, Nakajima Y, Takeichi S, Fujita MQ. Plasma remnant like lipoprotein particles or LDL-C as major pathologic factors in sudden cardiac death cases. Atherosclerosis 2008; 198: 237-46.
18. Boquist S, Ruotolo G, Tang R, et al. Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intimamedia thickness in healthy, middle-aged men. Circulation 1999; 100: 723-8.
19. ter Avest E, Holewijn S, Bredie SJ, Stalenhoef AF, de Graaf J. Remnant particles are the major determinant of an increased intima media thickness in patients with familial combined hyperlipidemia (FCH). Atherosclerosis 2007; 191: 220-6.
20. Misuguchi Y, Ito T, Owada K. Pathologic findings in rabbit models of hereditary hypertriglyceridemia and hereditary postprandial hypertriglyceridemia. Comp Med 2008; 58: 465-80.
21. Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 1994; 106: 83-97.
22. Groot PH, van Stiphout WA, Krauss XH, et al. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 1991; 11: 653-62.
23. Patsch JR, Miesenbock G, Patsch W. Relation of triglyceride metabolism and coronary disease. Studies in the postprandial state. Arterioscler Thromb 1992; 12: 1336-45.
24. Bansal S, Buring JE, Rifai N, et al. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007; 298: 309-16.
25. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Non fasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007; 298: 299-308.
26. Wilhelm MG, Cooper AD. Induction of atherosclerosis by human chylomicron remnants: a hypothesis. J Atheroscler Thromb 2003; 10: 132-9.
27. Kadar A, Glasz T. Development of atherosclerosis and plaque biology. Cardiovasc Surg 2001; 9: 109-21.
28. Proctor SD, Vine DF, Mamo JCL. Arterial retention of apolipoprotein B(48)- and B(100)- containing lipoproteins in atherosclerosis. Curr Opin Lipidol 2002; 13: 461-70.
29. Proctor SD, Mamo JC. Intimal retention of cholesterol derived from apolipoprotein B100- and apolipoprotein B48-containing lipoproteins in carotid arteries of Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol 2003; 23: 1595-600.
30. Proctor SD, Vine DF, Mamo JCL. Arterial permeablility and efflux of apolipoprotein B-containing lipoproteins assessed by in situ perfusion and three-dimensional quantitative confocal microscopy. Arterioscler Thromb Vasc Biol 2004; 24: 2162-7.
31. Pal S, Semorine K, Watts GF, Mamo J. Identification of lipoproteins of intestinal origin in human atherosclerotic plaque. Clin Chem Lab Med 2003; 41: 792-5.
32. Rapp JH, Lespine A, Hamilton RL, et al. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler Thromb 1994; 14: 1767-74.
33. Chung BH, Tallis G, Yalamoori V, Anantharamaiah GM, Segrest JP. Liposome-like particles isolated from human atherosclerotic plaques are structurally and compositionally similar to surface remnants of triglyceride rich lipoproteins. Arterioscler Thromb 1994; 14: 622-35.
34. Botham KM, Bravo E, Elliott J, Wheeler-Jones CPD. Direct interaction of dietary lipids carried in chylomicron remnants with cells of the artery wall: implications for atherosclerosis development. Curr Pharm Design 2005; 11: 3681-95.
35. Wheeler-Jones CPD. Chylomicron remnants: mediators of endothelial dysfunction? Biochem Soc Trans 2007; 35: 442-5.
36. Perona JS, Cabello Moruno R, Ruiz-Gutierrez V. Modulation of the effects of chylomicron remnants on endothelial function by minor dietary lipid components. Biochem Soc Trans 2007; 35: 446-50.
37. Norata GD, Catapano AL. Triglyceride-rich lipoproteins from normotryglyceridemic subjects and hyperlipidemic patients differently affect endothelial cell activation and gene expression patterns. Circ Res 2007; 100: 381-90.
38. Norata GD, Grigore L, Raselli S, et al. Triglyceride-rich lipoproteins from hypertriglyceridemic subjects induce a pro-inflammatory response in the endothelium: molecular mechanisms and gene expression studies. J Mol Cell Cardiol 2006; 40: 484-94.
39. Botham KM, Moore EH, De Pascale C, and Bejta F. The induction of macrophage foam cells by chylomicron remnants. Biochem Soc Trans 2007; 35: 454-8.
40. Bentley C, Hathaway N, DePascale C, et al. Influence of dietary fats on human monocyte activation in vitro. Atheroscler Suppl 2008; 9: 99-100.
41. Miller GJ, Martin JC, Mitropoulos KA, et al. Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat composition. Atherosclerosis 1991; 86: 163-71.
42. Byrne CD, Wareham NJ, Martensz ND, et al. Increased PAI activity and PAI-1 antigen occurring with an oral fat load: associations with PAI-1 genotype and plasma active TGF- levels. Atherosclerosis 1998; 140: 45-53.
43. Hyson DA, Paglieroni TG, Wun T, Rutledge JC. Postprandial lipemia is associated with platelet and monocyte activation and increased monocyte cytokine expression in normolipemic men. Clin Appl Thromb Hemost 2002; 8: 147-55.
44. Fuhrman B, Brook JG, Aviram M. Increased platelet aggregation during alimentary hyperlipemia in normal and hypertriglyceridemic subjects. Ann Nutr Metab 1986; 30: 250-60.
45. Packard CJ. Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease. Curr Opin Lipidol 2006; 17: 412-7.
46. Stalenhoef AFH, de Graaf J. Association of fasting and non fasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL. Curr Opin Lipidol 2008; 19: 355-61.
47. Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 2002; 43: 1363-79.
48. Noto D, Rizzo M, Barbagallo CM, et al. Low-density lipoproteins generated during an oral fat load in mild hypertrigyceridemic and healthy subjects are smaller, denser and have an increased lowdensity lipoprotein receptor binding affinity. Metabolism 2006; 55: 1308-16.
49. Koba S, Tsunoda F, Hirano T, et al. Postprandial changes in LDL phenotypes in patients with myocardial infarction. Eur J Clin Invest 2005; 35: 171-9.
50. Blackburn P, Cote M, Lamarche B, et al. Impact of postprandial variation in triglyceridemia on low-density lipoprotein particle size. Metabolism 2003; 52: 1379-86.
51. Rizzo M, Berneis K. Lipid triad or atherogenic lipoprotein phenotype: a role in cardiovascular prevention? J Atheroscler Thromb 2005; 12: 237-9.
52. Lairon D. Macronutrient uptake and modulation on chylomicron production and clearance. Atheroscler Suppl 2008; 9: 45-8.
53. Dubois C, Beaumier G, Juhel C, et al. Effects of graded amounts (0-50 g) of dietary fat on postprandial lipemia and lipoproteins in normolipidemic adults. Am J Clin Nutr 1998; 67: 31-8.
54. Zampelas A, Peel AS, Gould BJ, Wright J, Williams CM. Polyunsaturated fatty acids of the n-6 and n-3 series: effects on postprandial lipid and apolipoprotein levels in healthy men. Eur J Clin Nutr 1994; 48: 842-8.
55. Tholstrup T, Miller GJ, Bysted A, Sandstrom B. Effect of individual dietary fatty acids on postprandial activation of blood coagulation factor VII and fibrinolysis in healthy young men. Am J Clin Nutr 2003; 77: 1125-32.
56. Sanders TA, de Grassi T, Miller GJ, Morrissey JH. Influence of fatty acid chain length and cis/trans isomerisation on postprandial lipemia and factor VII in healthy subjects (postprandial lipids and factor VII). Atherosclerosis 2000; 149: 413-20.
57. Berry SE, Miller GJ, Sanders TA. The solid fat content of stearic acid-rich fats determines their postprandial effects. Am J Clin Nutr 2007; 85: 1486-94.
58. Harris WS, Bulchandani D. Why do omega-3 fatty acids lower serum triglycerides? Curr Opin Lipidol 2006; 17: 387-93.
59. Harris WS, Muzio F. Fish oil reduces postprandial triglyceride concentrations without accelerating lipid-emulsion removal rates. Am J Clin Nutr 1993; 58: 68-74.
60. Williams CM, Moore F, Morgan L, Wright J. Effects of n-3 fatty acids on postprandial triglyceride and hormone concentrations in normal subjects. Br J Nutr 1992; 68: 655-66.
61. Westphal S, Orth M, Ambrosch A, Osmundsen K, Luley C. Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n-3 fatty acids. Am J Clin Nutr 2000; 71: 914-20.
62. Kelley DS, Siegel D, Vemuri M, Mackey BE. Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men. Am J Clin Nutr 2007; 86: 324-33.
63. Rein P, Saely CH, Aczel S, Patsch B, Drexel H. Omega-3 fatty acids significantly reduce postprandial triglyceridemia in male smokers: a pilot study. Nutr Metab Cardiovasc Dis 2009; 19: e3-4.
64. Lairon D, Play B, Jourdheuil-Rahmani D. Digestible and indigestible carbohydrates: interactions with postprandial lipid metabolism. J Nutr Biochem 2007; 18: 217-27.
65. Livesey G, Taylor R. Fructose consumption and consequence for glycation, plasma triacylglcyerol, and body weight: meta-analyses and meta-regression models of intervention studies. Am J Clin Nutr 2008; 88: 1419-37.
66. Harbis A, Perdreau S, Vincent-Baudry S, et al. Glycemic and insulinemic meal responses modulate postprandial hepatic and intestinal lipoprotein accumulation in obese, insulin-resistant subjects. Am J Clin Nutr 2001; 80: 896-902.
67. Khossousi A, Binns CW, Dhaliwal SS, Pal S. The acute effects of psyllium on postprandial lipaemia and thermogenesis in overweight and obese men. Br J Nutr 2008; 99: 1068-75.
68. Mortensen LS, Hartvingsen ML, Brader LJ, et al. Differential effects of protein quality on postprandial lipemia in response to a fat-rich meal in type 2 diabetes: comparison of whey, casein, gluten and cod protein. Am J Clin Nutr 2009; 90: 41-8.
69. Mente A, de Koning L, Shannon HS, Anand SS. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 2009; 169: 659-69.
70. Basu A, Lucas EA. Mechanisms and effects of green tea on cardiovascular health. Nutr Rev 2007; 65: 361-75.
71. Abia R, Pacheco YM, Perona JS, Montero E, Muriana FJ, RuizGutiérrez V. The metabolic availability of dietary triacylglycerols from two high oleic oils during the postprandial period does not depend on the amount of oleic acid ingested by healthy men. J Nutr 2001; 131: 59-65.
72. Castro Cabezas M, de Vries JH, van Oostrum AJ, Iestra J, van Staveren WA. Effects of a stanol-enriched diet on plasma cholesterol and triglycerides in patients treated with statins. J Am Diet Assoc 2006; 106: 1564-9.
73. O'Keefe JH, Gheewala NM, O'Keefe JO. Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health. J Am Coll Cardiol 2008; 51: 249-55.
74. Naissides M, Mamo JC, James AP, Pal S. The effect of acute red wine polyphenol consumption on postprandial lipaemia in postmenopausal women. Atherosclerosis 2004; 177: 401-8.
75. Mero N, Syvanne M, Eliasson B, Smith U, Taskinen MR. Postprandial elevation of ApoB-48-containing triglyceride-rich particles and retinyl esters in normolipemic males who smoke. Arterioscler Thromb Vasc Biol 1997; 17: 2096-102.
76. MacEneaney OJ, Harrison M, O'Gorman DJ, et al. Effect of prior exercise on postprandial lipemia and markers of inflammation and endothelial activation in normal weight and overweight adolescent boys. Eur J Appl Physiol 2009; 106: 721-9.
77. Singhal A, Trilk JL, Jenkins NT, Bigelman KA, Cureton KJ. Effect of intensity of resistance exercise on postprandial lipemia. J Appl Physiol 2009; 106: 823-9.
78. Pafili ZK, Bogdanis GC, Tsetsonis NV, Maridaki M. Postprandial lipemia 16 and 40 hours after low-volume eccentric resistance exercise. Med Sci Sports Exerc 2009; 41: 375-82.
79. Murphy MH, Blair SN, Murtagh EM. Accumulated versus continuous exercise for health benefit: a review of empirical studies. Sports Med 2009; 39: 29-43.
80. Bloomer RJ, Fisher-Wellman KH. Postprandial oxidative stress in exercise trained and sedentary cigarette smokers. Int J Environ Res Public Health 2009; 6: 579-91.
81. Pastromas S, Terzi AB, Tousoulis D, Koulouris S. Postprandial lipemia: an under-recognized atherogenic factor in patients with diabetes mellitus. Int J Cardiol 2008; 126: 3-12.
82. Zimmet P, Alberti KGMM, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-7.
83. Hsieh J, Hayashi AA, Webb J, Adeli K. Postprandial dyslipidemia in insulin resistance: Mechanisms and role of intestinal insulin sensitivity. Atheroscler Suppl 2008; 9: 7-13.
84. Adeli K, Lewis GF. Intestinal lipoprotein overproduction in insulin-resistant states. Curr Opin Lipidol 2008; 19: 221-8.
85. Duez H, Pavlic M, Lewis GF. Mechanism of intestinal lipoprotein overproduction in insulin resistant humans. Atheroscler Suppl 2008; 9: 33-8.
86. Tomkin GH. The intestine as a regulator of cholesterol homeostasis in diabetes. Atheroscler Suppl 2008; 9: 27-32.
87. Castro Cabezas M, Halkes CJ, Erkelens DW. Obesity and free fatty acids: double trouble. Nutr Metab Cardiovasc Dis 2001; 11: 134-42.
88. Adiels M, Olofsson S-O, Taskinen M-R, Borén J. Overproduction of Very Low-Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome. Arterioscler Thromb Vasc Biol 2008; 28: 1225-36.
89. Gibbons GF, Wiggins D, Brown AM, Hebbachi AM. Synthesis and function of hepatic very-low-density lipoprotein. Biochem Soc Trans 2004; 32: 59-64.
90. Hussain MM, Rava P, Pan X, et al. Microsomal triglyceride transfer protein in plasma and cellular lipid metabolism. Curr Opin Lipidol 2008; 19: 277-84.
91. Adiels M, Westerbacka J, Soro-Paavonen A, et al. Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance. Diabetologia 2007; 50: 2356-65.
92. Lam TKT, Gutierrez-Juarez R, Pocai A, et al. Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins. Nat Med 2007; 13: 171-80.
93. Cianflone K, Paglialunga S, Roy C. Intestinally derived lipids: metabolic regulation and consequences - an overview. Atheroscler Suppl 2008; 9: 63-8.
94. Potenza MA, Addabbo F, Montagnani M. Vascular actions of insulin with implications for endothelial dysfunction. Am J Physiol Endocrinol Metab 2009; 297: E568-77.
95. Iida KT, Suzuki H, Sone H, et al. Insulin inhibits apoptosis of macrophage cell line, THP-1 cells, via phosphatidylinositol-3-kinase-dependent pathway. Arterioscler Thromb Vasc Biol 2002; 22: 380-6.
96. Vine DF, Glimm DR, Proctor SD. Intestinal lipid transport and chylomicron production: Possible links to exacerbated atherogenesis in a rodent model of the metabolic syndrome. Atheroscler Suppl 2008; 9: 69-76.
97. Camejo G, Olsson U, Hurt-Camejo E, Baharamian N, Bondjers G. The extracellular matrix on atherogenesis and diabetes-associated vascular disease. Atheroscler Suppl 2002; 3: 3-9.
98. Cianflone K, Xia Z, Chen LY. Critical review of acylationstimulating protein physiology in humans and rodents. Biochim Biophys Acta 2003; 1609: 127-43.
99. Musso G, Gambino R, Durazzo M, et al. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Hepatology 2005; 42: 1175-83.
100. Matikainen N, Manttari S, Westerbacka J, et al. Posprandial lipemia associates with liver fat content. J Clin Endocrinol Metab 2007; 92: 3052-9.
101. Ginsberg HN, Illingworth DR. Postprandial dyslipidemia: an atherogenic disorder common in patients with diabetes mellitus. Am J Cardiol 2001; 88: 9-15.
102. Mortimer BC, Holthouse DJ, Martins IJ, Stick RV, Redgrave TG. Effects of triacylglycerol-saturated acyl chains on the clearance of chylomicron-like emulsions from the plasma of the rat. Biochim Biophys Acta 1994; 1211: 171-80.
103. Mangat R, Su J, Scott PG, et al. Chylomicron and apoB48 metabolism in the JCR:LA corpulent rat, a model for the metabolic syndrome. Biochem Soc Trans 2007; 35: 477-81.
104. Levy E, Spahis S, Ziv E, et al. Overproduction of intestinal lipoprotein containing apolipoprotein B-48 in Psammamys obesus: impact of dietary n-3 fatty acids. Diabetologia 2006; 49: 1937-45.
105. Volek JS, Phinney SD, Forsythe CE, et al. Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet. Lipids 2008; 44: 297-309.
106. Zhang JQ, Ji LL, Fogt DL, Fretwell VS. Effect of exercise duration on postprandial hypertriglyceridemia in men with metabolic syndrome. J Appl Physiol 2007; 103: 1339-45.
107. Mestek ML, Plaisance EP, Ratcliffe LA, et al. Aerobic exercise in postprandial lipemia in men with the metabolic syndrome. Med Sci Sports Exerc 2008; 40: 2105-11.
108. Graham I, Atar D, Borch-Johnsen K. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J 2007; 28: 2375-414.
109. Weintraub MS, Grosskopf I, Rassin T, et al. Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years. BMJ 1996; 312: 936-9.
110. Cohn JS. Are we ready for a prospective study to investigate the role of chylomicrons in cardiovascular disease? Atherosclerosis Suppl 2008; 9; 15-8.
111. Lairon D, Lopez-Miranda J, Williams C. Methodology for studying postprandial lipid metabolism. Eur J Clin Nutr 2007; 61: 1145-61.
112. van Oostrom AJ, Alipour A, Sijmonsma TP, et al. Comparison of different methods to investigate postprandial lipaemia. Neth J Med 2009; 67: 13-20.
113. Karpe F. Postprandial lipid metabolism in relation to coronary heart disease. Proc Nutr Soc 1997; 56: 671-8.
114. Kinoshita M, Kojima M, Matsushima T, Teramoto T. Determination of apolipoprotein B-48 in serum by a sandwich ELISA. Clin Chim Acta 2005; 351: 115-20.
115. Iso H, Naito Y, Sato S, et al. Serum triglycerides and risk of coronary heart disease among Japanese men and women. Am J Epidemiol 2001;153: 490-9.
116. Karpe F. Effects of diet on postprandial lipaemia: a suggestion for methodological standardization. Nutr Metab Cardiovasc Dis 1997; 7: 44-55.
117. Russell Warnick G, Nakajima K. Fasting versus Nonfasting Triglycerides: Implications for laboratory measurements. Clin Chem 2008; 54: 14-6.
118. Smith SJ, Cooper GR, Myers GL, Sampson EJ. Biological variability in concentrations of serum lipids: sources and variation among results from published studies and composite predicted values. Clin Chem 1993; 39: 1012-22.
119. Delawi D, Meijssen S, Castro Cabezas M. Intra-individual variations of fasting plasma lipids, apolipoproteins and postprandial lipemia in familial combined hyperlipidemia compared to controls. Clin Chim Acta 2003; 328: 139-45.
120. [120] Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 1998; 81: 7B-12B.
121. Stampfer MJ, Krauss RM, Ma J, et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 1996; 276: 882-8.
122. Kolovou GD, Anagnostopoulou KK, Daskalopoulou SS, Mikhailidis DP, Cokkinos DV. Clinical relevance of postprandial lipaemia. Curr Med Chem 2005; 12: 1931-45.
123. Sarwar N, Danesh J, Eiriksdottir G, et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation 2007; 115: 450-8.
124. Eberly LE, Stamler J, Neaton JD. Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease. Arch Intern Med 2003; 163: 1077-83.
125. Patel A, Barzi F, Jamrozik K, et al. Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation 2004; 110: 2678-86.
126. Mora S, Rifai N, Buring JE, Ridker PM. Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events. Circulation 2008; 118: 993-1001.
127. Musso G, Gambino R, De Michieli F, et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 2003; 37: 909-16.
128. Ridker MP. Fasting versus nonfasting triglycerides and the prediction of cardiovascular risk: do we need to revisit the oral triglyceride tolerance test? Clin Chem 2008; 54: 11-3.
129. Dubois C, Armand M, Azais-Braesco V, et al. Effects of moderate amounts of emulsified dietary fat on postprandial lipemia and lipoproteins in normolipidemic adults. Am J Clin Nutr 1994; 60: 374-82.
130. Lairon D. Nutritional and metabolic aspects of postprandial lipemia. Reprod Nutr Dev 1996; 36: 345-55.
131. Weintraub MS, Zechner R, Brown A, Eisenberg S, Breslow JL. Dietary polyunsaturated fats of the W-6 and W-3 series reduce postprandial lipoprotein levels. Chronic and acute effects of fat saturation on postprandial lipoprotein metabolism. J Clin Invest 1988; 82: 1884-93.
132. Beaumier-Gallon G, Dubois C, Senft M, et al. Dietary cholesterol is secreted in intestinally derived chylomicrons during several subsequent postprandial phases in healthy humans. Am J Clin Nutr 2001; 73: 870-7.
133. Thomsen C, Rasmussen O, Lousen T, et al. Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects. Am J Clin Nutr 1999; 69: 1135-43.
134. Mekki N, Charbonnier M, Borel P, et al. Butter differs from olive oil and sunflower oil in its effects on postprandial lipemia and triacylglycerol-rich lipoproteins after single mixed meals in healthy young men. J Nutr 2002; 132: 3642-9.
135. Hofmann SM, Tschöp MH. Dietary sugars: a fat difference. J Clin Invest 2009; 119: 1089-92.
136. Ginsberg HN, KarmallyW, Siddiqui M, et al. A dose-response study of the effects of dietary cholesterol on fasting and postprandial lipid and lipoprotein metabolism in healthy young men. Arterioscler Thromb 1994; 14: 576-86.
137. [137] Romon M, Le Fur C, Lebel P, et al. Circadian variation of postprandial lipemia. Am J Clin Nutr 1997; 65: 934-40;
138. Hadjadj S, Paul JL, Meyer L, et al. Delayed changes in postprandial lipid in young normolipidemic men after a nocturnal vitamin A oral fat load test. J Nutr 1999; 129: 1649-55.
139. Burdge GC, Jones AE, Frye SM, Goodson L,Wootton SA. Effect of meal sequence on postprandial lipid, glucose and insulin responses in young men. Eur J Clin Nutr 2003; 57: 1536-44.
140. Guerci B, Paul JL, Hadjadj S, et al. Analysis of the postprandial lipid metabolism: use of a 3-point test. Diabetes Metab 2001; 27: 449-57.
141. Rivellese AA, De Natale C, Di Marino L, et al. Exogenous and endogenous postprandial lipid abnormalities in type 2 diabetic patients with optimal blood glucose control and optimal fasting triglyceride levels. J. Clin Endocr Metab 2004; 89: 2153-9.
142. Tentolouris N, Eleftheriadou I, Katsilambros N. The effects of medications used for the management of dyslipidemia on postprandial lipemia. Curr Med Chem 2009; 16: 203-17.
143. Margetts B, Warm D, Yngve A, Sjöström M. Developing an evidence-based approach to Public Health Nutrition: translating evidence into policy. Public Health Nutr 2001; 4: 1393-7.
144. WHO/FAO: Diet, nutrition and the prevention of chronic diseases. World Health Organ Tech Rep Ser 2003; 916: i-viii, 1-149, backcover
145. Beaudry M, Delisle H. Public('s) nutrition. Public Health Nutr 2005; 8: 743-8.